Overview of Stratamed

Quick Facts

Property	Description
Active Ingredient	Polysiloxanes, Siloxane Resin
Form	Self-Drying Transparent Gel
Pharmacological Class	Film-Forming Silicone Dressing
Origin	Synthetic Polymer
Common Use	Maintaining a Moist Wound Environment

What Type of Dressing is Stratamed and How is it Classified?

Stratamed is an advanced, self-drying gel preparation primarily categorized as a Medical Device from the manufacturer Stratpharma AG in Switzerland. Its classification is rooted in physical action, not systemic biochemistry. The transparent gel is designed for immediate topical application, rapidly curing into a flexible, protective film. Wound dressings of this type are utilized in wound management to provide protection and a moist environment. The regulatory filing confirms the product's function as a physical, protective layer for compromised skin.

This designation as a Medical Device underscores its role as a Film-Forming Silicone Dressing. It is noted for its ability to stabilize the wound bed by establishing a non-adherent, continuous full contact layer over the affected area, unlike traditional sheet dressings.

Composition and Origin: What Makes Stratamed a Polymer-Based Gel?

The core of Stratamed is a combination product composed of the synthetic polymer materials Polysiloxanes and Siloxane Resin, which form the silicone gel base. These constituents are defined as inert materials and non-transdermal polymers, distinguishing the product because it remains strictly on the skin's surface and is not intended for systemic absorption.

This composition ensures the product is biocompatible and suitable for sensitive patient groups, including infants and breastfeeding mothers. Its ability to dry quickly into a thin, non-sticky film is a differentiating factor that allows flexibility of use on mobile areas or under sunblock.

General Purpose: How Does this Semi-Occlusive Dressing Support Skin Management?

The general purpose of Stratamed is to maintain a stable, moist wound healing environment, a condition crucial for effective tissue repair. Functioning as a semi-occlusive dressing, the cured film is selectively gas permeable yet entirely waterproof, preventing environmental contamination while allowing necessary oxygen exchange. Silicone gels can stabilize mast cells and reduce the tension and irritation that contribute to scar formation. Maintaining a stable silicone barrier helps ease discomfort and supports optimal tissue organization.

By providing this sealed, hydrating barrier, the preparation helps manage the factors that lead to an exaggerated inflammatory response and is instrumental in facilitating effective re-epithelialization and general skin management, particularly after acute injuries like first- and second-degree burns.

Therapeutic Uses of Stratamed

The core therapeutic domains of Stratamed are focused on the local management of compromised skin and the prevention of abnormal scarring, a function associated with the therapeutic category of film-forming silicone dressings. The therapeutic category of film-forming silicone products is generally relevant when supportive symptom management is appropriate for tissue repair.

Quick Fact: Relief for Scarring Discomfort

The gel is commonly used for managing conditions associated with acute or disruptive episodes, such as superficial wounds, abrasions, lacerations, first or second-degree burns, and following surgical procedures. It is applied to help address symptom clusters that may become intense or disruptive, such as pronounced redness, skin tightness, and persistent itching that are characteristic of scar maturation.

The product may be part of symptomatic management in contexts marked by increased discomfort or tension during the skin recovery process. The use of the gel provides support that helps ease the overall symptom load and discomfort associated with healing. This assists with maintaining functional stability for sensitive patient groups, including infants and pregnant mothers, and contributes to easing the overall symptom load and supports general well-being during symptomatic periods.

Eligibility and Restrictions for Use

Stratamed is a film-forming silicone gel wound dressing indicated for use on open wounds, compromised skin, and for the prevention and treatment of abnormal scars like hypertrophic scars and keloids.

It is designed to be biocompatible and non-reactive, which allows for a broad range of users.

Who Can Use Stratamed?

Stratamed is considered suitable for all skin types and is often recommended for use in the following populations:

Children and Infants: The formulation is inert, without alcohol, parabens, or fragrances, making it appropriate for sensitive skin and pediatric use.
Pregnant and Breastfeeding Women: Systemic absorption is not expected, so it is considered safe for use during pregnancy and while breastfeeding.
Individuals with Sensitive Skin: The non-reactive composition is generally well-tolerated.

When Should Stratamed Be Avoided?

While Stratamed has a strong safety profile, there are specific wound types and conditions where its use is not recommended or requires professional consultation:

Wet, Highly Exudative Wounds: The gel is generally not suitable for wounds with excessive fluid drainage.
Tunneling Wounds: This refers to wounds that have tracts extending in one or more directions from the surface.
Deep or Third-Degree Burns: It is not intended for the initial management of deep burns and should only be applied to third-degree burns after the presence of granulation tissue and under medical supervision.
Over Other Topical Products: Unless specifically advised by a physician, do not apply other medicated products underneath Stratamed, as the silicone film may prevent their absorption.

What should I know about interactions with other medicines?

Stratamed Interactions with other medicines and products

Stratamed is an advanced film-forming wound dressing officially classified as a Medical Device, not a systemically acting drug. Its active components, Polysiloxanes and Siloxane Resin, are inert and non-transdermal polymers. The official interaction profile, therefore, lacks documented systemic drug-drug interactions.

Systemic Interaction Profile

Interaction Type	Official Regulatory Status
Pharmacokinetic (e.g., CYP Enzymes)	None documented. The inert, non-transdermal nature of the gel means it has no effect on drug metabolism, clearance, or systemic exposure (AUC/Cmax).
Pharmacodynamic	None documented. The product has no pharmacological activity and does not contribute to additive or opposing effects with systemic medicines.
Food, Alcohol, Supplements	None documented. Regulatory documents do not state restrictions or interactions with food, alcohol, or herbal products.

Physical Administration Restriction

Interacting Class	Interaction Restriction
Other Topical Treatments	Not to be applied over other topical medicines or moisturizers. The self-drying film creates a semi-occlusive barrier that can physically prevent the subsequent absorption or penetration of other products applied to the same area.

This interaction profile is solely governed by the product’s function as a physical barrier. No systemic interaction contraindications are listed in regulatory sources, and the product is cited as suitable for all populations, including infants and pregnant individuals, without specific interaction-related adjustments.

Mechanism of Action

️ How Stratamed Works

Stratamed employs a biophysical mechanism centered on modulating the skin's surface environment rather than through direct pharmacological interaction. This action is achieved by forming an inert, semi-occlusive barrier that initiates a cascade of modulatory physiological changes.

Modulation of Epidermal Hydration and Feedback Signaling

The primary mechanism involves the Polysiloxanes and Siloxane Resin rapidly curing into a flexible film that significantly reduces Trans-Epidermal Water Loss (TEWL). This action increases and sustains the hydration of the stratum corneum, which functions as a critical mechanistic signal influencing epidermal barrier integrity. The stable, moist environment acts as a negative feedback to the keratinocytes, which results in a down-regulation of the release of pro-fibrotic signaling molecules.

️ Suppression of Pro-Fibrotic Cascade

The suppression of pro-fibrotic mediators from the epidermal layer reduces the proliferation and synthetic activity of underlying dermal fibroblasts. This physiological adjustment limits the overproduction and disorganized deposition of collagen, which is the core process influenced by this mechanism. The continuous contact and structural integrity of the film is essential, as the resulting physiological effects are dependent on the persistent nature of the protective barrier.

Dosage and Administration Information

Stratamed is an advanced film-forming, self-drying silicone gel indicated for use on open wounds, compromised skin, and for the prevention and treatment of abnormal scars such as hypertrophic scars and keloids. For optimal results, the gel should be maintained in continuous contact with the affected area for 24 hours a day.

Application Instructions

Preparation: Ensure the affected skin or wound is clean and dry. Gently pat away any excess wound fluid or exudate before application.
Application: Apply a very thin layer of Stratamed to the area, covering it completely. The gel does not need to be rubbed in.
Drying Time: If the area is left uncovered, allow the gel to self-dry for approximately 5–6 minutes. If the product remains sticky after this time, too much has been applied. Gently blot the excess with a clean tissue or gauze to allow the drying process to continue.
Covering: Once dry, Stratamed can be covered with clothing, cosmetics, or sunscreen. If a protective secondary dressing is required, apply a thin layer of the gel and cover with the dressing immediately; drying is not necessary in this case.

Stratamed is typically applied once or twice daily, or as instructed by a healthcare provider. If the gel is washed off, it should be immediately reapplied. The recommended minimum treatment duration for abnormal scar prevention is 60–90 days, or until no further improvement is observed.

Recent Clinical Evidence

Research Evidence Overview

This section summarizes the structure and nature of the clinical research for the gel, focusing on the study types, populations, and outcomes measured, as reported in peer-reviewed scientific literature and regulatory documents. Research does not determine whether an individual will respond similarly; findings describe group patterns, not personal outcomes.

Research Exploring Use in Post-Surgical Settings and Scar Outcomes

Research examining the product following surgical procedures primarily includes short-term randomized controlled trials (RCTs) and observational studies. These studies were applied in research contexts involving routine procedures, such as specific types of skin cancer removal or hair transplants, and typically included adult populations. Researchers measured outcomes related to early wound response (e.g., presence of crusting, edema, and erythema) and patient-reported preferences for the dressing. Long-term data on the final scar appearance are not fully established.

Research Exploring Application on Open Wounds and Compromised Skin

The evidence base for the gel was evaluated in settings involving open wounds and compromised skin, such as first- and second-degree burns, and is primarily derived from observational studies and case reports. This research examined temporary physiological imbalance in patients presenting with conditions associated with acute or disruptive episodes. Outcomes related to systemic or functional imbalance were observed, with studies exploring how the application affected the process of new skin formation, known as re-epithelialization. The Evidence Level is generally categorized as Low, and comparative evidence against other advanced wound care dressings may be lacking.

Studies Examining Symptom Patterns and Patient Preference

The gel was studied in research exploring outcomes related to physical discomfort during the healing process. Research has explored short-term symptom changes, primarily using patient-reported outcome (PRO) studies. The studies focused on episodes where symptoms become more noticeable, such as itching (pruritus), pain, and general discomfort. Findings often rely on subjective patient feedback, and the generalizability appears to be narrow.

Evidence Gaps and Areas of Research Uncertainty

Sample sizes were modest in several key product-specific trials, which makes it challenging to generalize findings to a wider patient population. Certainty remains low in areas where findings were mixed or where the studies focused on the silicone gel class in general rather than on this specific product. Follow-up durations were limited, meaning the long-term outcomes are not fully established. The product was evaluated across a broad demographic, including infants and breastfeeding mothers, but data for certain groups with complex skin conditions remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Stratamed (FAQ)

Q: Is it normal for Stratamed to cause a slight temporary stinging feeling when applied near the eyes?

According to official product information, the evaporation process that allows the gel to dry can sometimes cause a temporary stinging feeling when applied near sensitive areas like the eyes. This sensation is generally reported to be temporary and mild. Caution is advised to avoid direct contact with the eyes, as stated in the product information.

Q: Does Stratamed have any known severe side effects?

Official safety data indicates that no severe side effects have been observed when Stratamed is used as directed. The most common local reactions are mild and non-systemic, such as itching, redness, or irritation. If severe reactions, pain, or persistent skin irritation are observed, it is recommended to discontinue use and seek guidance from a healthcare professional.

Q: Why is it recommended to use a very thin layer of Stratamed?

Official application guidance emphasizes using a very thin layer primarily to ensure the gel can dry properly and quickly. If too much is applied, the film may remain sticky, which means it may not be forming the correct protective layer.

Q: Are there any known medications or topical creams that interact with Stratamed?

As Stratamed is classified as an inert medical device and is non-transdermal (meaning it is not absorbed), it has no systemic drug-drug interactions. However, product instructions advise that other topical creams or medications generally should not be applied underneath the gel, due to its function as a physical barrier.

Q: Why is Stratamed considered bacteriostatic?

Official product information states that Stratamed is bacteriostatic, which means it has the ability to hinder bacteria from reproducing within the wound bed. This feature supports the product's role as a dressing for open wounds and compromised skin, as stated in the product description.

Q: Can Stratamed be used on burns, and if so, what degree of burns?

The product is indicated for use on first and second-degree burns that are not highly exudative (very wet). Use is not intended for deep, complex, or third-degree burns, and application in these situations requires specific medical guidance.

Q: Can Stratamed be used to help with skin compromised by conditions like CPAP prong pressure injuries?

Official product information specifies that Stratamed can be used on compromised skin areas, including skin breakdown such as nasal septal injury from CPAP prongs and other pressure injuries from medical devices.

Q: Does Stratamed come in different sizes, and how long does a tube last?

Stratamed is available in several tube sizes (e.g., 5g, 10g, 20g), which are intended for different treatment lengths. The tube's duration is estimated based on the product size and the dimensions of the area being managed, with larger tubes intended for longer treatment periods.

Q: What evidence or research supports the use of Stratamed for scar prevention?

Research summaries indicate that the gel supports optimal healing by regulating hydration. Studies exploring its use report favorable results in supporting wound closure and helping to prevent the formation of abnormal scars after various surgical procedures. However, long-term data on final scar appearance may be limited.

Q: Is Stratamed safe for use on people with known allergies to adhesives or certain tapes?

Official product information notes that the gel is composed of inert, biocompatible polymers and does not contain many common adhesives or glues (like acrylate monomers) found in some tapes. This composition is considered suitable for sensitive patient groups.

Q: Does Stratamed have a noticeable odor?

Official product information indicates that the gel is formulated to be odorless.

Q: Is Stratamed registered as a medical device or a cosmetic product?

Stratamed is primarily classified as an advanced film-forming wound dressing. Regulatory bodies classify the product as a Class IIa medical device because its primary function is physical protection and wound management through film formation, not systemic pharmacological action.

--רת

Q: What kind of wounds resulting from chemical peels or tattoo removal can Stratamed be used on?

Product information indicates that Stratamed is used on compromised skin resulting from various procedures, including ablative laser resurfacing, chemical peels, tattoo removal, and other dermal procedures.

Q: Why is Stratamed referred to as a film-forming wound dressing?

Stratamed is described as a film-forming wound dressing because, upon application, it quickly dries to form a thin, transparent, and flexible protective sheet designed to maintain continuous contact with the affected area.

Q: Does Stratamed have an expiry date?

Yes, the product has an expiration date (EXP) printed on the tube and box. Official storage requirements state that the expiration date remains unchanged once the product has been opened.

How should Stratamed be stored and disposed of?

How to Store and Dispose of Stratamed?

Stratamed must be stored and handled according to the instructions on its official regulatory label to maintain product integrity and ensure safety.

Storage Requirements

Storage Rule	Requirement
Child Safety	Keep out of the reach of children.
Container Integrity	The tube must be reclosed tightly with the cap after each use.
Product Stability	Do not use after the expiration (EXP) date printed on the tube; the EXP date remains unchanged once the tube has been opened.

No specific storage temperature range or instructions for protection from light or moisture are consistently documented in regulatory summaries.

Disposal Protocol

Stratamed disposal should follow federal guidelines for non-hazardous medical products. Unused or expired product should be mixed with an undesirable substance, sealed, and placed in the household trash. Before discarding the original container, scratch out all identifying information on the label.

Category	Officially Documented Safety Entities
Adverse Reactions	Pruritus (Itching), Erythema (Redness), Irritation, Pain at Application Site
Frequency Classification	Adverse reactions are generally categorized as uncommon or not common in regulatory safety labeling.
Serious Reactions	No specific serious adverse reactions are routinely highlighted in core regulatory documentation resulting from the inert silicone components.

Stratamed